Table 2.
Laboratory parameters of patients with early-stage (group 1) and advanced-stage (group 2) of DKD.
| Laboratory features | Group 1 | Group 2 | p |
|---|---|---|---|
| n = 28 | n = 48 | ||
| 25(OH)D (ng/mL) | 30.0 ± 8.0 | 26.3 ± 9.8 | 0.03 |
| Glucose (mg/dL) | 130.7 ± 40.2 | 161.6 ± 61.2 | 0.02 |
| HbA1c (%) | 7.9 ± 0.9 | 8.2 ± 1.3 | 0.17 |
| Creatinine (mg/dL) | 0.84 ± 0.24 | 1.4 ± 0.4 | <0.001 |
| GFR (CKD-EPI) (mL/min/1,73m²) | 88.3 ± 17.4 | 51.2 ± 14.4 | <0.001 |
| Total cholesterol (mg/dL) | 160.0 ± 46.2 | 187.2 ± 48.7 | 0.02 |
| HDL (mg/dL) | 40.6 ± 12.5 | 40.4 ± 10.5 | 0.93 |
| LDL (mg/dL) | 86.3 ± 35.3 | 100.8 ± 43.3 | 0.15 |
| Triglycerides (mg/dL) | 171.0 ± 84.9 | 233.6 ± 153.0 | 0.05 |
| Mean albuminuria (mg/g) | 105.0 ± 67.7 | 614.0 ± 585.0 | <0.001 |
| Mean albuminuria (log10) | 1.9 ± 0.3 | 2.6 ± 0.5 | <0.001 |
25(OH)D, 25-hydroxyvitamin D; HbA1c, Glycated hemoglobin; GFR, Glomerular Filtration Rate; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; HDL, High-density lipoprotein; LDL, Low-density lipoprotein.